Polyanhydride microparticles enhance dendritic cell antigen presentation and activation.
about
Particle-mediated delivery of cytokines for immunotherapyPolyanhydride Nanovaccines Induce Germinal Center B Cell Formation and Sustained Serum Antibody ResponsesNanoparticle-allergen complexes for allergen immunotherapy.Safety and biocompatibility of carbohydrate-functionalized polyanhydride nanoparticles.Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants.Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen.High-throughput synthesis of carbohydrates and functionalization of polyanhydride nanoparticlesBiodegradable particles as vaccine delivery systems: size mattersCharacterizing the antitumor response in mice treated with antigen-loaded polyanhydride microparticlesApplications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases.Respiratory nanoparticle-based vaccines and challenges associated with animal models and translationMaterials that harness and modulate the immune system.Combinatorial evaluation of in vivo distribution of polyanhydride particle-based platforms for vaccine delivery.Self-assembled PEG-b-PDPA-b-PGEM copolymer nanoparticles as protein antigen delivery vehicles to dendritic cells: preparation, characterization and cellular uptakeRecent advances in polymeric microspheres for parenteral drug delivery--part 2.Targeting antigens to dendritic cell receptors for vaccine developmentApplying biodegradable particles to enhance cancer vaccine efficacy.Nanoparticle based-immunotherapy against allergy.The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response.Functionalization promotes pathogen-mimicking characteristics of polyanhydride nanoparticle adjuvants.Surface-modified P(HEMA-co-MAA) nanogel carriers for oral vaccine delivery: design, characterization, and in vitro targeting evaluation.Biocompatibility of polysebacic anhydride microparticles with chondrocytes in engineered cartilage.A systems approach to designing next generation vaccines: combining α-galactose modified antigens with nanoparticle platforms.Carbohydrate-functionalized nanovaccines preserve HIV-1 antigen stability and activate antigen presenting cells.Harvesting murine alveolar macrophages and evaluating cellular activation induced by polyanhydride nanoparticles.The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation.Evaluation of biocompatibility and administration site reactogenicity of polyanhydride-particle-based platform for vaccine delivery.Exploiting the pliability and lateral mobility of Pickering emulsion for enhanced vaccination.Emerging trends in the immunotherapy of pancreatic cancer.Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf.Single immunization with a suboptimal antigen dose encapsulated into polyanhydride microparticles promotes high titer and avid antibody responses.Pathogen-Mimicking Polymeric Nanoparticles based on Dopamine Polymerization as Vaccines Adjuvants Induce Robust Humoral and Cellular Immune Responses.Chemically modified inulin microparticles serving dual function as a protein antigen delivery vehicle and immunostimulatory adjuvant.Room Temperature Stable PspA-Based Nanovaccine Induces Protective Immunity.Polyanhydride Nanovaccine Induces Robust Pulmonary B and T Cell Immunity and Confers Protection Against Homologous and Heterologous Influenza A Virus Infections
P2860
Q26997993-C53CEF84-E6F3-4E7C-8439-E0AA7AD035DEQ33710195-1EFA89AD-2B9A-4B07-A152-5D171FF311A1Q33834985-7F618AAD-2279-4FC1-8EF7-548402F4A62BQ34871862-48F9DEFB-DA2F-45C8-87C0-49CAD5992F47Q35619618-B61A534D-D2E6-4A97-94B5-EAAB1A0EA6ABQ35887551-94C671FB-6928-4D20-8659-2D050F70D7B7Q36317368-37D492CD-715F-4860-88B3-3601687ACCA0Q36502434-754E4F7E-C406-4640-B8F9-E03802B82394Q36582010-EA9A1514-82CD-46A9-95BF-A7CF2B72AD6FQ36591050-37A2214A-A233-40EE-A685-7EF0502C6A61Q36598433-86EC16AF-13D0-4BEF-878B-0A4D27444009Q36690859-3200EE33-56AE-4ADC-843A-E17C5449AAE8Q36957938-21B26C07-E9CD-4EF9-807E-C81EEE22C7F9Q37611358-E7661997-B094-47C2-AC0F-FF447B89078FQ38038244-D69618AE-44D5-48E3-8BB7-D23672B91BBFQ38162446-229293EB-3CDB-4442-881D-F6B292BB1853Q38212549-40ED7CBF-AA17-403A-A007-EBEB6C722428Q38257645-ADA8BFD2-1274-4A98-9BF8-97B0AA7D7487Q38722460-0F7ACB9F-BCDB-4513-99AC-933F93165AD0Q38757220-FACCD67B-291C-4100-8ED5-BBF9649C2C03Q38982074-E1D5789B-FF38-4F32-BC04-7733CE993FA2Q41382718-9BF4A932-CCD7-47FF-9960-ADC30516F45DQ41879397-A9A4221D-53B2-4D60-A73F-01647CBC4AC9Q42114702-74C47F0D-1026-4743-A059-8F4FBAB6771FQ42426154-D5A8E606-0769-4EC5-9901-3E47A93B3491Q42926219-AE93933E-2091-47DB-9B28-7118B3BC9BA8Q46989472-78B97370-00D1-4307-BADB-8B61D49C483AQ47201342-04FBA98E-73FC-4AA8-8C9A-B9F821C851A6Q47248817-5C1BC247-45B1-425C-8492-68B161E11547Q50317606-D39DFFB4-05B0-4638-99F6-CEC6A5EE70CDQ50928936-E78AAD95-D140-4A3B-9F54-43C7254265EEQ51534139-0AC1B417-EB78-4F0F-A228-B4B5D88F86FDQ51567300-8E8466BD-A46D-4D3D-87D3-5B23AA1B957CQ51732398-C64B49BE-4994-4ECD-B430-C9884162F89BQ57167166-389DFBF4-B76C-45AB-93A8-8197D5D0A7AE
P2860
Polyanhydride microparticles enhance dendritic cell antigen presentation and activation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Polyanhydride microparticles enhance dendritic cell antigen presentation and activation.
@en
Polyanhydride microparticles enhance dendritic cell antigen presentation and activation.
@nl
type
label
Polyanhydride microparticles enhance dendritic cell antigen presentation and activation.
@en
Polyanhydride microparticles enhance dendritic cell antigen presentation and activation.
@nl
prefLabel
Polyanhydride microparticles enhance dendritic cell antigen presentation and activation.
@en
Polyanhydride microparticles enhance dendritic cell antigen presentation and activation.
@nl
P2093
P2860
P1433
P1476
Polyanhydride microparticles enhance dendritic cell antigen presentation and activation
@en
P2093
Balaji Narasimhan
Brenda Carrillo-Conde
Bryan H Bellaire
Maria P Torres
Michael J Wannemuehler
Senja K Lopac
Yashdeep Phanse
P2860
P304
P356
10.1016/J.ACTBIO.2011.03.023
P577
2011-03-23T00:00:00Z